If you will be attending this year’s AMERICAN NEUROGASTROENTEROLOGY AND MOTILITY SOCIETY (ANMS) conference, make sure to find us at the Hands-on Neurogastroenterology & Motility Procedures Session. Join us in the Harborside Ballroom on July 27th at 5:30 p.m. to learn more about Enterra® Therapy and the potential mechanism of action of #GastricElectricalStimulation! #gastroparesis #anms2024 #neurogastroenterology Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. RX only. Review important safety information: https://lnkd.in/gYjd8mKi MKT-SM-02285, Rev A
Enterra Medical, Inc.
Medical Equipment Manufacturing
Minneapolis, Minnesota 3,770 followers
Helping more people find relief from nausea and vomiting symptoms of gastroparesis through Enterra® Therapy.
About us
Enterra Medical is a medical device company dedicated to a singular focus: helping more people with chronic gastroparesis live better lives by advancing technology, expanding clinical science, and accelerating access to the Enterra® Therapy.* In order to increase investment and focus on the therapy, Enterra Medical was formed in 2022 and has begun the process to assume ongoing responsibility of Enterra Therapy from Medtronic. This process began with commercial responsibilities and will continue to expand to other aspects of the business. Medtronic remains a strong operational partner in this new management model and will continue to handle customer and patient support until Enterra Medical is fully equipped to assume those functions. Gastroparesis is a condition in which food moves through the stomach too slowly, causing chronic nausea and vomiting. Enterra Therapy, approved by the FDA under a Humanitarian Device Exemption in 2000, may be a surgical option for certain people who are unable to control chronic symptoms of gastroparesis.* It is the first and only implantable therapy for Gastric Electrical Stimulation, and over 15,000 people have received Enterra Therapy to help resume everyday activities. Consult with a doctor to see if Enterra Therapy may be an option for you. *Humanitarian Device. Enterra Therapy is authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. Visit www.enterramedical.com/important-safety-information/ for important safety information.
- Website
-
http://www.enterramedical.com
External link for Enterra Medical, Inc.
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Minneapolis, Minnesota
- Type
- Privately Held
- Founded
- 2022
- Specialties
- nausea, vomiting, gastroparesis, diabetes, gastric electrical stimulation, neurostimulation, neurostimulator, GES, and intractable nausea
Locations
-
Primary
Minneapolis, Minnesota, US
Employees at Enterra Medical, Inc.
Updates
-
Enterra Medical is pleased to announce that we will be attending this year’s AMERICAN NEUROGASTROENTEROLOGY AND MOTILITY SOCIETY (ANMS) conference! Make sure to visit us at table #9 to learn about Enterra® Therapy, the first and only device of its kind targeting the #nausea and #vomiting symptoms associated with #gastroparesis from diabetic or idiopathic origins. #anms2024 #neurogastroenterology Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. RX only. Review important safety information: https://lnkd.in/gYjd8mKi MKT-SM-02022, Rev A
-
See what Enterra Medical has been up to at this year’s American Society For Metabolic And Bariatric Surgery (ASMBS) annual meeting in San Diego, California! Visit us at booth #619 to learn more about the latest insights in #gastroparesis and Enterra® Therapy as an advanced treatment option. #ASMBS2024 #EnterraTherapy #Gastroenterology #Nausea #Vomiting Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. RX only. Review important safety information: https://lnkd.in/gYjd8mKi MKT-SM-01967 Rev A
-
Huge congratulations to Jeffrey S Fronza, MD, FACS from Northwestern Medicine Central DuPage Hospital on successfully performing his first implant of the Enterra® Therapy System! We're especially proud to see Dr. Fronza's achievement, knowing that he participated in one of Enterra Medical's educational peer-to-peer programs. These initiatives provide valuable resources to surgeons like Dr. Fronza, empowering them to bring innovative therapies to their #gastroparesis patients. Thank you, Dr. Fronza, for your commitment to improving patient outcomes and increasing access to advanced therapies. Your expertise and passion are making a real difference in the lives of many. #gastroenterology #nausea #vomiting #GPAwareness Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. Rx Only. Review Important Safety Information: lnkd.in/eCr5zfhK MKT-SM-02020, Rev A
-
See what Enterra Medical has been up to at this year’s Digestive Disease Week® (DDW) annual conference. Stop by booth #1231 to learn about how you can offer hope and help to your #gastroparesis patients with Enterra® Therapy–an advanced treatment option in their journey to relief from #nausea and #vomiting. #DDW2024 #GI #gastroenterology #EnterraTherapy Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. RX only. Review important safety information: https://lnkd.in/gYjd8mKi MKT-SM-01876, Rev A
-
If your patients are looking for treatment options for chronic nausea and vomiting from diabetic or idiopathic #gastroparesis, we’re here to help. Encourage them to join our upcoming live patient education discussion on May 2 at 11:30 a.m. CST to learn more about gastric electrical stimulation with Enterra® Therapy. Registration can be accessed here: https://lnkd.in/gUYf3z3u #GPAwareness #gastroenterology #nausea #vomiting Safety info: tinyurl.com/2c3bktnk
-
Enterra Medical is excited to attend this year’s Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) conference in Cleveland, Ohio! Come visit booth #631 to connect with Enterra Medical’s leadership team to learn about their focus on future technologies, clinical science, and increasing patient access to #EnterraTherapy. #gastroparesis #gastroenterology #nausea #vomiting #SAGES2024 Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. RX only. Review important safety information: https://lnkd.in/gYjd8mKi MKT-SM-01788, Rev B
-
Enterra Medical is committed to providing educational opportunities for health care professionals. We want to extend a sincere thank you to all who attended The Advanced Strategies in Gastroparesis Management: Enterra® Therapy Comprehensive Course in Charlotte, North Carolina this past weekend. We are grateful to our presenters Matthew Brengman, MD, Reena Chokshi, MD, Diana McFarlane, PA-C, Kenneth Koch, MD and Bjorn Barner for your expertise covering imperative topics such as new insights on #gastroparesis, the latest clinical data, surgical case studies, and sharing best practices in patient selection. We are thankful for your partnership, and for your dedication to helping gastroparesis patients take back their seat at the table! #Gastroenterology #Nausea #Vomiting #GPAwareness
-
If your patients are looking for treatment options for chronic nausea and vomiting from #gastroparesis, we’re here to help. Encourage them to join our upcoming live patient education discussion to learn more about gastric electrical stimulation with Enterra® Therapy. Register here: https://lnkd.in/ghRYZTGD #GPAwareness #gastroenterology #nausea #vomiting Safety info: tinyurl.com/2c3bktnk
-
If your patients are looking for treatment options for chronic nausea and vomiting from #gastroparesis, we’re here to help. Encourage them to join our upcoming live patient education discussion to learn more about gastric electrical stimulation with Enterra® Therapy. Register here: tinyurl.com/3pcytnv3 #GPAwareness #gastroenterology #nausea #vomiting Safety info: tinyurl.com/2c3bktnk